Geoff is a director and heads the ECM activities for Oaklins Cavendish, one of Oaklins’ member firms in the UK. He has over 20 years’ corporate finance experience in growth companies, having advised on all aspects of IPO, M&A and secondary funding. Geoff has advised clients across a range of sectors, with a particular focus on life sciences. His clients include Avacta plc, Synairgen plc, Bioventix plc and Tristel plc.
Prior to joining the team, Geoff qualified with KPMG and previously worked in private equity. He also spent seven years at Evolution Securities (formerly Beeson Gregory and now part of Investec).